The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index.
Prevalence, Treatment, and Control of Diagnosed Diabetes in the U.S. National Health and Nutrition Examination Survey 1999–2004
Abstract
Purpose This study aimed to examine the trends in prevalence, treatment, and control of diagnosed diabetes in United States adults 20 years of age or older.Methods Data from the National Health and Nutrition Examination Survey 1999-2004 were used. Glycemic, blood pressure, and total cholesterol target levels were defined as having glycosylated hemoglobin <7.0%, blood pressure <130/80 mm Hg, and total cholesterol <200 mg/dL, respectively.Results The prevalence of diagnosed diabetes was 7.8% in 2003-2004 and increased significantly in people aged 40-59 years, women, non-Hispanic whites, and obese people in the period 1999-2004. Although there was no significant change in the pattern of antidiabetic treatment, the age-adjusted percentage of people with diagnosed diabetes achieving glycemic and blood pressure target levels increased from 35.8% to 57.1% (p = 0.002) and from 35.7% to 48.3% (p = 0.04), respectively. However, there were only insignificant increases in percentages of those persons achieving total cholesterol target level (from 48.8% to 50.4%) and those achieving all 3 target levels (from 7.5% to 13.2%).Conclusions In 1999-2004, the prevalence of diagnosed diabetes increased significantly in some subgroups of the population. However, the increases in percentages of people with diabetes achieving glycemic and blood pressure targets are encouraging, although there is room for improvement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular many racial/ethnic minority groups (particularly Blacks/African-Americans and Hispanics-Latinos) are at greater risk of obesity, heart disease, diabetes, and cardiovascular events (204, 206, 207).”
From Sleep: important considerations for the prevention of cardiovascular disease (2016) · cites this paper as [207]
In the citing paper
“African-Americans and Mexican-Americans are at greater risk of developing diabetes compared to non-Hispanic whites [3]”
From Association between sleep deficiency and cardiometabolic disease: implications for health disparities (2016) · cites this paper as [3]
In the citing paper
“Unfortunately, racial/ethnic and socioeconomic disparities in these diseases exist such that minority populations, such as African Americans and Hispanics, and those of lower socioeconomic status, experience a greater burden.”
From Association between sleep deficiency and cardiometabolic disease: implications for health disparities (2016) · cites this paper as [3]
Citations
Cites
1 retracted
Thiazolidinediones for the treatment of type 2 diabetes
Elte, J. W. F., & Blickle, J. (2007) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2006.09.007 · Cited by 77
RetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Flagged first, then by citations
2 of the 35 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Klein, 2001, Age adjustment using the 2000 projected US population, Healthy People 2010 Stat Notes, 20, 1
- American Diabetes Association, 2001, Standards of medical care for patients with diabetes mellitus, Diabetes Care, 24, S33, 10.2337/diacare.24.11.1988 · DOI
Cited by
Sorted by citations
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Mosca, L., Benjamin, E. J., Berra, K., Bezanson, J. L., Dolor, R. J., Lloyd-Jones, D. M., Newby, L. K., Piña, I. L., Roger, V. L., Shaw, L. J., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820faaf8 · Cited by 2,143
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update
Mosca, L. J., Benjamin, E. J., Berra, K. A., Bezanson, J. L., Dolor, R. J., Lloyd‐Jones, D. M., Newby, L. K., Piña, I. L., Roger, V. L., Shaw, L. J., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.005 · Cited by 795
Goldstein, L. B., Bushnell, C., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · Cited by 745
Sleep disparity, race/ethnicity, and socioeconomic position
Grandner, M. A., Williams, N. J., Knutson, K. L., Roberts, D., & Jean-Louis, G. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2015.01.020 · Cited by 481
Glycemic control and complications in type 2 diabetes mellitus
Stolar, M. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.12.004 · Cited by 356
Diabetes Prevalence and Therapeutic Target Achievement in the United States, 1999 to 2006
Cheung, B. M. Y., Ong, K. L., Cherny, S. S., Sham, P. C., Tso, A. W. K., & Lam, K. S. L. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.047 · Cited by 349
McWilliams, J. M., Meara, E., Zaslavsky, A. M., & Ayanian, J. Z. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-8-200904210-00005 · Cited by 315
Risk Factors for Heart Failure: A Population-Based Case-Control Study
Dunlay, S. M., Weston, S. A., Jacobsen, S. J., & Roger, V. L. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.04.022 · Cited by 313
Heise, T., Seewaldt-Becker, E., Macha, S., Hantel, S., Pinnetti, S., SEMAN, L. J., & Woerle, H. J. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12073 · Cited by 277
Patient adherence to medication requirements for therapy of type 2 diabetes
Bailey, C. J., & Kodack, M. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02544.x · Cited by 267
The Impact of Treatment Noncompliance on Mortality in People With Type 2 Diabetes
Currie, C. J., Peyrot, M. F., Morgan, C. L., Poole, C., Jenkins‐Jones, S., Rubin, R. R., Burton, C. M., & Evans, M. (2012) · Diabetes Care · doi:10.2337/dc11-1277 · Cited by 261
Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes
Rosenstock, J., Reusch, J. E. B., Bush, M., Yang, F., Stewart, M. W., & for the Albiglutide Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0366 · Cited by 241
Åhrén, B., JOHNSON, S. L., Stewart, M. W., Cirkel, D. T., Yang, F., Perry, C., & Feinglos, M. N. (2014) · Diabetes Care · doi:10.2337/dc14-0024 · Cited by 228
Wyman, J. F., Burgio, K. L., & Newman, D. K. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02078.x · Cited by 224
Pharmacology of Dipeptidyl Peptidase-4 Inhibitors
Baetta, R., & Corsini, A. (2011) · Drugs · doi:10.2165/11591400-000000000-00000 · Cited by 213
Brehm, B. J., Lattin, B. L., Summer, S. S., Boback, J. A., Gilchrist, G. M., Jandacek, R. J., & D’Alessio, D. A. (2009) · Diabetes Care · doi:10.2337/dc08-0687 · Cited by 196
Glycaemic control in type 2 diabetes: Targets and new therapies
Tahrani, A. A., Piya, M. K., Kennedy, A., & Barnett, A. H. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.001 · Cited by 190
Unraveling the Science of Incretin Biology
Nauck, M. A. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.03.012 · Cited by 168
Sleep: important considerations for the prevention of cardiovascular disease
Grandner, M. A., Alfonso-Miller, P., Fernandez-Mendoza, J., Shetty, S., Shenoy, S., & Combs, D. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000324 · Cited by 166
Alzaheb, R., & Altemani, A. (2018) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s156214 · Cited by 160
Adverse effects and safety of SGLT-2 inhibitors
Halimi, S., & Vergès, B. L. (2014) · Diabetes & Metabolism · doi:10.1016/s1262-3636(14)72693-x · Cited by 165
Burrows, N. R., Li, Y., & Geiss, L. S. (2009) · Diabetes Care · doi:10.2337/dc09-0343 · Cited by 158
Ratner, R. E., Rosenstock, J., Boka, G., & on behalf of the DRI6012 Study Investigators (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03020.x · Cited by 155
Sodium-Glucose Co-Transport Inhibitors
Neumiller, J. J., White, J. R., & Campbell, R. K. (2010) · Drugs · doi:10.2165/11318680-000000000-00000 · Cited by 156
Why are we failing to implement effective therapies in cardiovascular disease?
Nieuwlaat, R., Schwalm, J.-D., Khatib, R., & Yusuf, S. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs481 · Cited by 155
Dipeptidyl Peptidase‐4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Neumiller, J. J., Wood, L. D., & Campbell, R. K. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.5.463 · Cited by 149
Fujita, Y., & Inagaki, N. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12214 · Cited by 152
Alonso, Á., Mosley, T. H., Gottesman, R. F., Catellier, D., Sharrett, A. R., & Coresh, J. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.176818 · Cited by 151
Neumiller, J. J. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.09078 · Cited by 144
Kurosaki, E., & Ogasawara, H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.003 · Cited by 136
Colesevelam lowers glucose and lipid levels in type 2 diabetes: The clinical evidence
Fonseca, V. A., Handelsman, Y., & Staels, B. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01181.x · Cited by 130
Megatrials in type 2 diabetes. From excitement to frustration?
Prato, S. D. (2009) · Diabetologia · doi:10.1007/s00125-009-1352-5 · Cited by 128
Evaluation of a hypertension medication therapy management program in patients with diabetes
Planas, L. G., Crosby, K. M., Mitchell, K. D., & Farmer, K. C. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.08164 · Cited by 128
Morrison, F. J. R. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.400 · Cited by 125
Rangaraj, V. R., & Knutson, K. L. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2015.02.535 · Cited by 120
Zinman, B., Schmidt, W. E., Moses, A. C., Lund, N., & Gough, S. C. L. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01493.x · Cited by 119
Lou, P., Qin, Y., Zhang, P., Chen, P., Zhang, L., Chang, G., Li, T., Qiao, C., & Zhang, N. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.060 · Cited by 126
Menke, A., Rust, K., FRADKIN, J. E., Cheng, Y. J., & Cowie, C. C. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0286 · Cited by 115
Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents
Lee, Y., Lingvay, I., Szczepaniak, L. S., Ravazzola, M., Orci, L., & Unger, R. H. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.245 · Cited by 121
Knutson, K. L., Wu, D., Patel, S. R., Loredo, J. S., Redline, S. S., Cai, J., Gallo, L. C., Mossavar‐Rahmani, Y., Ramos, A. R., Teng, Y., et al. (2017) · SLEEP · doi:10.1093/sleep/zsx014 · Cited by 113
Giaconi, J. A., Yu, F., Stone, K. L., Pedula, K. L., Ensrud, K. E., Cauley, J. A., Hochberg, M. C., & Coleman, A. L. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.03.048 · Cited by 110
Adeniyi, O. V., Yogeswaran, P., Longo‐Mbenza, B., & Goon, D. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150033 · Cited by 112
Are Individuals With Diabetes Seeing Better?
Klein, R., & Klein, R. (2010) · Diabetes · doi:10.2337/db09-1904 · Cited by 109
Plosker, G. L. (2012) · Drugs · doi:10.2165/11209910-000000000-00000 · Cited by 99
Clarifying the Role of Incretin-Based Therapies in the Treatment of Type 2 Diabetes Mellitus
Campbell, R. K. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.04.015 · Cited by 92
Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the CoLaus study
Kaiser, A. V., Vollenweider, P., Waeber, G., & Marques-Vidal, P. M. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03422.x · Cited by 92
The Hypertension–Diabetes Continuum
Cheung, B. M. Y. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181d26430 · Cited by 89
Chen, X., He, Z., Zhou, Z., Yang, T., Zhang, X., Yang, Y., Duan, W., & Zhou, S. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12455 · Cited by 91
Pi-Sunyer, X. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.09.2056 · Cited by 88
Rees, C. A., Karter, A. J., & Young, B. A. (2010) · The Diabetes Educator · doi:10.1177/0145721710364419 · Cited by 83
Sims, M., Diez Roux, A. V., Boykin, S., Sarpong, D., Gebreab, S. Y., Wyatt, S. B., Hickson, D., Payton, M., Ekunwe, L., & Taylor, H. A. (2011) · Annals of Epidemiology · doi:10.1016/j.annepidem.2011.05.006 · Cited by 81
“Diabetes control for men and women in our sample was lower than the national total for African Americans in the US as of 2004 (3) (35.”
BackgroundFord, E. S. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00148.x · Cited by 79
Wang, C., Yu, Y., Zhang, X., Li, Y., Chang-gui, K., Li, B., Tao, Y., Zhen, Q., He, H., Kanu, J. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103594 · Cited by 74
Abbott, S. M., Weng, J. F., Reid, K. J., Daviglus, M. L., Gallo, L. C., Loredo, J. S., Nyenhuis, S. M., Ramos, A. R., Shah, N. A., Sotres‐Alvarez, D., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.09.018 · Cited by 74
Prevalence of diabetes in Northern African countries: the case of Tunisia
Romdhane, H. B., Ali, S. B., Aissi, W., Traissac, P., Skhiri, H. A., Bougatef, S., Maire, B., Delpeuch, F., & Achour, N. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-86 · Cited by 72
Joubert, M., & Reznik, Y. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.12.010 · Cited by 70
Progress Toward Universal Health Coverage
Rahman, M. M., Karan, A., Rahman, M. S., Parsons, A. J. Q., Abe, S. K., Bilano, V. L. F., Awan, R. P., Gilmour, S., & Shibuya, K. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.3133 · Cited by 70
Efficacy of the Smartphone-Based Glucose Management Application Stratified by User Satisfaction
Kim, H.-S., Choi, W., Baek, E. K., Kim, Y. A., Yang, S. J., Choi, I. Y., Yoon, K.-H., & Cho, J.-H. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.3.204 · Cited by 68
Dailey, G. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.04.025 · Cited by 66
Trends of ABC control 2006–2011: A National Survey of Diabetes Health Promotion Institutes in Taiwan
Yu, N.-C., Su, H.-Y., Chiou, S.-T., Yeh, M. C., Yeh, S.-W., Tzeng, M.-S., & Sheu, W. H. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.11.018 · Cited by 67
Initial Combination Therapy for Type 2 Diabetes Mellitus: Is It Ready for Prime Time?
Zinman, B. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.11.003 · Cited by 66
Estoppey, D., Paccaud, F. M., Vollenweider, P., & Marques-Vidal, P. M. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-114 · Cited by 64
Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus
Kennedy, L., & Freeman, J. S. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76.s5.03 · Cited by 63
Mexico-California Diabetes collaborative group, Barquera, S., Schillinger, D., Aguilar-Salinas, C. A., Schenker, M. B., Rodríguez, L. A., Hernández-Alcaraz, C., & Sepúlveda-Amor, J. (2018) · Globalization and Health · doi:10.1186/s12992-018-0390-5 · Cited by 62
Unraveling the Science of Incretin Biology
Nauck, M. A. (2009) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2009.05.012 · Cited by 62
Lee, H. J., Kim, H. C., Vı́tek, L., & Nam, C. M. (2010) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.56.13 · Cited by 64
Defining and Achieving Treatment Success in Patients With Type 2 Diabetes Mellitus
STOLAR, M. W. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0471 · Cited by 60
Kuznik, A., & Mardekian, J. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-31 · Cited by 59
Methylglyoxal in diabetes: link to treatment, glycaemic control and biomarkers of complications
Beisswenger, P. J. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130275 · Cited by 60
Trends in the prevalence and management of diabetes in Korea: 2007-2017
Shin, J.-Y. (2019) · Epidemiology and Health · doi:10.4178/epih.e2019029 · Cited by 60
Morrison, F. J. R., Shubina, M., & Turchin, A. (2012) · Diabetes Care · doi:10.2337/dc11-1635 · Cited by 59
Are current clinical trials in diabetes addressing important issues in diabetes care?
Lakey, W. C., Barnard, K., Batch, B. C., Chiswell, K., Tasneem, A., & Green, J. B. (2013) · Diabetologia · doi:10.1007/s00125-013-2890-4 · Cited by 55
Poucher, S. M., Cheetham, S. C., Francis, J., Zinker, B. A., Kirby, M., & Vickers, S. P. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01619.x · Cited by 51
The Epidemiology of Diabetic Retinopathy
Klein, R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-563-3_3 · Cited by 51
Vega‐López, S., Chavez, A., Farr, K. J., & Ainsworth, B. E. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-29 · Cited by 52
Current Concepts in Diabetic Retinopathy
Song, S. J., & Wong, T. Y. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.6.416 · Cited by 47
Fritz, J., Phillips, A., Hunt, L., Imam, A., Reid, K., Perreira, K., Mossavar-Rahmani, Y., Daviglus, M., Sotres-Alvarez, D., Zee, P., et al. (2020) · Sleep · doi:10.1093/sleep/zsaa218 · Cited by 36
Frier, B. M., Russell-Jones, D. L., & Heise, T. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12106 · Cited by 46
Predictors of parent–child relationships that support physical activity in Mexican–American families
de la Haye, K., de Heer, H. ‘., Wilkinson, A. V., & Koehly, L. M. (2012) · Journal of Behavioral Medicine · doi:10.1007/s10865-012-9471-8 · Cited by 45
Saxagliptin: A dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
Neumiller, J. J., & Campbell, R. K. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp090555 · Cited by 42
Changing the Treatment Paradigm for Type 2 Diabetes
Prato, S. D., Penno, G., & Miccoli, R. (2009) · Diabetes Care · doi:10.2337/dc09-s314 · Cited by 42
Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects
Pereira, T. D. M. C., Pimenta, F. S., Porto, M. L., Baldo, M. P., Campagnaro, B. P., Gava, A. L., Meyrelles, S. S., & Vasquez, E. C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081273 · Cited by 43
Excess Frequent Insufficient Sleep in American Indians/Alaska Natives
Chapman, D. P., Croft, J. B., Liu, Y., Perry, G. S., Presley-Cantrell, L. R., & Ford, E. S. (2013) · Journal of Environmental and Public Health · doi:10.1155/2013/259645 · Cited by 43
Owolabi, E. O., Goon, D. T., Adeniyi, O. V., & Seekoe, E. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014349 · Cited by 45
Borrell, L. N., Crawford, N. D., Dallo, F. J., & Baquero, M. (2009) · Public Health Reports · doi:10.1177/003335490912400512 · Cited by 42
Dapagliflozin: more than just another oral glucose-lowering agent?
Katsiki, N., Παπάνας, Ν., & Mikhailidis, D. P. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.539558 · Cited by 39
Cardiovascular safety and diabetes drug development
Drucker, D. J., & Goldfine, A. B. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62299-4 · Cited by 38
Abubakari, A., Jones, M. C., Lauder, W., Kirk, A. F., Devendra, Anderson, J. V., & Naderali, E. K. (2013) · International Journal of General Medicine · doi:10.2147/ijgm.s46649 · Cited by 41
Diabetes after Kidney Donation
Ibrahim, H. N., Kukla, A., Cordner, G., Bailey, R., Gillingham, K. J., & Matas, A. J. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02944.x · Cited by 40
Use Of Medical Care For Chronic Conditions
Decker, S. L., Schappert, S. M., & Sisk, J. E. (2009) · Health Affairs · doi:10.1377/hlthaff.28.1.26 · Cited by 38
Factors associated with glycemic control in type 2 diabetic patients in Saudi Arabia
AlMetwazi, M. S., Alwhaibi, M., Balkhi, B. S., Almohaini, H. A., Alturki, H., Alhawassi, T. M., Ata, S. I., Alqahtani, N., Mahmoud, M. A., & Alshammari, T. M. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.12.007 · Cited by 37
Rombopoulos, G., Hatzikou, M., Latsou, D., & Yfantopoulos, J. (2013) · HORMONES · doi:10.14310/horm.2002.1443 · Cited by 34
Wilding, J. P. H., Bailey, C. J., Rigney, U., Blak, B. T., Kok, M. D., & Emmas, C. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.04.004 · Cited by 33
Nguyen, Q. C., Whitsel, E. A., Tabor, J. W., Cuthbertson, C. C., Wener, M. H., Potter, A., Halpern, C. T., Killeya‐Jones, L. A., Hussey, J. M., Suchindran, C., et al. (2014) · Annals of Epidemiology · doi:10.1016/j.annepidem.2014.09.010 · Cited by 34
Colorectal Cancer Screening Among Primary Care Patients: Does Risk Affect Screening Behavior?
Felsen, C. B., Piasecki, A. K., Ferrante, J. M., Ohman‐Strickland, P., & Crabtree, B. F. (2011) · Journal of Community Health · doi:10.1007/s10900-010-9348-0 · Cited by 33
Gerber, B. S., Rapacki, L., Castillo, A., Tilton, J., Touchette, D. R., Mihailescu, D., Berbaum, M. L., & Sharp, L. K. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-891 · Cited by 33
Predictors of poor glycaemic control in older patients with type 2 diabetes mellitus
Sazlina, S. G., Mastura, I., Cheong, A. T., Bujang, M. A., Jamaiyah, H., Lee, P. Y., Alwi, S. S., & Chew, B. (2015) · Singapore Medical Journal · doi:10.11622/smedj.2015055 · Cited by 35
Alabousi, M., Abdullah, P., Alter, D. A., Booth, G. L., Hogg, W., Ko, D. T., Manuel, D. G., Farkouh, M. E., Tu, J. V., & Udell, J. A. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.005 · Cited by 31
Metadata
- Authors
- Ong, K. L., Cheung, B. M. Y., Wong, L. Y. F., Wat, N. M. S., Tan, K. C. B., & Lam, K. S. L.
- Affiliations
- University of Hong Kong (HK)
- Corresponding author
- Cheung, Bernard M.Y.
- Venue
- Annals of Epidemiology
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 18
- Issue
- 3
- Pages
- 222-229
- ISSN
- 1047-2797 (ISSN-L)
- OpenAlex
- W2029084557
- Cited by
- 232
- References
- 35
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 8 · 2020: 7 · 2019: 6 · 2018: 6 · 2017: 8 · 2016: 9 · 2015: 13 · 2014: 21 · 2013: 21 · 2012: 22
- FWCI
- 25.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diagnosed diabetes, diabetes prevalence, diabetes treatment, glycemic control, blood pressure control, cholesterol management, HbA1c, antidiabetic therapy, diabetes trends, obesity, sex differences, racial differences
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Nutrition Surveys, Regression Analysis, United States, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review